Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma

Published:2017 Issue:3 Volume:23 Page:540
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Zhu Han-Ting,Ai Da-Shan,Tang Hua-Rong,Badakhshi Harun,Fan Jian-Hong,Deng Jia-Ying,Zhang Jun-Hua,Chen Yun,Zhang Zhen,Xia Yi,Guo Xiao-Mao,Jiang Guo-Liang,Zhao Kuai-Le

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference23 articles.

1. INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

2. Chemoradiotherapy of Locally Advanced Esophageal Cancer

3. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.

4. Does Paclitaxel Improve the Chemoradiotherapy of Locoregionally Advanced Esophageal Cancer? A Nonrandomized Comparison With Fluorouracil-Based Therapy

5. Improved local control by surgery and paclitaxel‐based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non‐randomized study

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re-irradiation of In- or Out-of-PTV Esophageal Recurrence after Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma;2023-06-26

2. Cardiotoxicity of Anti-Cancer Radiation Therapy: a Focus on Heart Failure;Current Heart Failure Reports;2023-01-24

3. Chemoradiotherapy with paclitaxel liposome plus cisplatin for locally advanced esophageal squamous cell carcinoma: A retrospective analysis;Cancer Medicine;2022-11-22

4. Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma;PLOS ONE;2022-10-13

5. Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases;Molecules;2022-04-11